Net Income

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.

HiddenLayer joins a massive $151B defense contract to secure AI systems, signaling a new era where protecting AI is critical for national missile defense.

PayPal is leveraging its vast transaction data to challenge ad giants, offering advertisers a direct view of actual purchases, not just clicks.

Subsidiary Stand-By Golf reports a 22% profit jump, showcasing parent company TMGI's successful strategy in the booming, tech-driven golf market.

With its rare disease drug JURVIGO® in late-stage trials, Mezzion appoints a veteran leader to navigate the path to approval and commercialization.

Visteon's new 'plug-and-play' AI module, powered by NVIDIA, aims to slash costs and complexity for automakers adding smart cockpit or ADAS features.

With a major new facility planned and a dynamic market, all eyes are on Clean Harbors as it prepares to address investors at two key January events.

The security tech firm expands its domestic violence monitoring to a 10th nation, signaling a major shift in Europe's public safety technology market.

CleanSpark boosts Bitcoin output by over 10% and pivots to AI data centers, all while helping stabilize the power grid in times of extreme demand.

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

A new partnership between Second Front Systems and Paramify leverages automation to slash software compliance times from years to months for government agencies.

In 2025, A&G saved retailers like Rite Aid and expanded its expertise to healthcare and life sciences, showcasing the power of strategic real estate.

With enrollment complete for three major trials, MediciNova braces for a transformative year with crucial data expected for its ALS and metabolic disease candidates.

Lazard Asset Management creates a new CIO role, appointing Eric Van Nostrand to unify its global investment platform amid fierce industry competition.

An Orlando firm is changing its payment model to ease client burdens, but a closer look reveals a complex story of community work and corporate history.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

With its lead muscular dystrophy drug in late-stage trials, Edgewise Therapeutics heads to the JPM conference with high stakes for its pipeline and stock.

Keysight Technologies taps Applied Materials veteran Liz Morali to lead investor relations, a strategic move to bolster market confidence and articulate its complex growth story.

SUI Group's appointment of former CFTC Commissioner Brian Quintenz signals a strategic push for regulatory credibility and institutional crypto adoption.